Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEN8744 Phase 1 Study in Healthy Volunteers
NCT06118385Phase 1Completed
- Sponsor
- BenevolentAI
- Start
- Aug 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BEN8744 in ulcerative colitis (UC) (12 arms), sponsored by BenevolentAI. Primary endpoints: Observer's Assessment of Alertness/Sedation Scale, Visual Analogue Scale and 5 more. Started Aug 2023; status: completed.
02
Drugs
BEN8744
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06118385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06118385.